David Goldstein

Pancreatic Research Group, University of New South Wales

Affiliated withUniversity of New South Wales

Research Area

Biography

medical oncologist, clinical trials,clinical and translational research experience

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 8	2020

Other Publications

Article	Year
Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification. The Journal of infectious diseases\| PubMed ID: 9728559	1998
Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians. Social science & medicine (1982)\| PubMed ID: 15110416	2004
Modern management of pancreatic carcinoma. Internal medicine journal\| PubMed ID: 15317546	2004
Understanding community beliefs of Chinese-Australians about cancer: initial insights using an ethnographic approach. Psycho-oncology\| PubMed ID: 15386778	2005
Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients. British journal of cancer\| PubMed ID: 15756253	2005
Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines. Cancer letters\| PubMed ID: 15922858	2005
Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study. Oncology\| PubMed ID: 16293972	2005
Phase II study of vinflunine in patients with metastatic renal cell carcinoma. Investigational new drugs\| PubMed ID: 16528478	2006
Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases. BMC cancer\| PubMed ID: 16674812	2006
Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC cancer\| PubMed ID: 17026776	2006
Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha. BJU international\| PubMed ID: 17346275	2007
Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer research\| PubMed ID: 18381413	2008
Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer? Australian health review : a publication of the Australian Hospital Association\| PubMed ID: 18666870	2008
Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. Cancer research\| PubMed ID: 18829522	2008
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. Cancer chemotherapy and pharmacology\| PubMed ID: 20461378	2011
Role of pancreatic stellate cells in pancreatic cancer metastasis. The American journal of pathology\| PubMed ID: 20934972	2010
Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. The oncologist\| PubMed ID: 21478275	2011
Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity. PloS one\| PubMed ID: 21494615	2011
If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer. The oncologist\| PubMed ID: 21835897	2011
Impact of oxaliplatin-induced neuropathy: a patient perspective. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 22426503	2012
New molecular and immunotherapeutic approaches in biliary cancer. ESMO open\| PubMed ID: 28848675	2017
Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 22508807	2012
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection. Digestive diseases and sciences\| PubMed ID: 22543885	2012
STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review). International journal of oncology\| PubMed ID: 22842992	2012
Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers. Molecular pharmaceutics\| PubMed ID: 23611705	2013
Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis. Journal of cancer research and clinical oncology\| PubMed ID: 23912151	2013
The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 24002504	2013
Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Genome medicine\| PubMed ID: 24004612	2013
Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer. Frontiers in physiology\| PubMed ID: 24478715	2014
Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA: a cancer journal for clinicians\| PubMed ID: 24590861	2013
Role of pancreatic stellate cells in chemoresistance in pancreatic cancer. Frontiers in physiology\| PubMed ID: 24782785	2014
The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer. Carcinogenesis\| PubMed ID: 24876152	2014
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations. Genetics in medicine : official journal of the American College of Medical Genetics\| PubMed ID: 25188872	2015
Impact of STAT3 inhibition on survival of osteosarcoma cell lines. Anticancer research\| PubMed ID: 25368256	2014
βIII-tubulin: a novel mediator of chemoresistance and metastases in pancreatic cancer. Oncotarget\| PubMed ID: 25544769	2015
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. Journal of the National Cancer Institute\| PubMed ID: 25638248	2015
The Potential of panHER Inhibition in Cancer. Frontiers in oncology\| PubMed ID: 25674538	2015
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 25801699	2015
Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables. The oncologist\| PubMed ID: 25802406	2015
Targeted therapy in soft tissue sarcoma-a novel direction in therapeutics. Chinese clinical oncology\| PubMed ID: 25841678	2013
"I might not have cancer if you didn't mention it": a qualitative study on information needed by culturally diverse cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 26093976	2016
A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services. Psycho-oncology\| PubMed ID: 26123474	2016
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial)... BMC cancer\| PubMed ID: 26228433	2015
Response. Journal of the National Cancer Institute\| PubMed ID: 26251330	2015
Key role of pancreatic stellate cells in pancreatic cancer. Cancer letters\| PubMed ID: 26571462	2016
Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma? European journal of cancer (Oxford, England : 1990)\| PubMed ID: 26702763	2016
Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer. British journal of cancer\| PubMed ID: 26766740	2016
Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial. BMC cancer\| PubMed ID: 26772734	2016
Using a Delphi process to determine optimal care for patients with pancreatic cancer. Asia-Pacific journal of clinical oncology\| PubMed ID: 26800012	2016
Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma. Oncotarget\| PubMed ID: 26909593	2016
Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 27086312	2016
Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures. American journal of human genetics\| PubMed ID: 27108799	2016
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Rand... JAMA\| PubMed ID: 27139057	2016
Erratum to: Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 27154013	2016
Determinants of Outcomes Following Resection for Pancreatic Cancer-a Population-Based Study. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract\| PubMed ID: 27184672	2016
Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus. The Medical journal of Australia\| PubMed ID: 27318402	2016
Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review. Cancer chemotherapy and pharmacology\| PubMed ID: 27497971	2017
Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence. OncoTargets and therapy\| PubMed ID: 27660463	2016
Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines. Anticancer research\| PubMed ID: 27793898	2016
Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review. Asia-Pacific journal of clinical oncology\| PubMed ID: 27860270	2017
MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity. Oncotarget\| PubMed ID: 27999205	2017
Communicating with patients from minority backgrounds: Individual challenges experienced by oncology health professionals. European journal of oncology nursing : the official journal of European Oncology Nursing Society\| PubMed ID: 28069155	2017
Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 28104535	2017
Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy. PloS one\| PubMed ID: 28125674	2017
Anxiety, depression and quality of life in people with pancreatic cancer and their carers. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]\| PubMed ID: 28153446	2017
Communication challenges experienced by migrants with cancer: A comparison of migrant and English-speaking Australian-born cancer patients. Health expectations : an international journal of public participation in health care and health policy\| PubMed ID: 28261937	2017
The role of chemotherapy in gastric cancer-related microangiopathic haemolytic anaemia. Journal of gastrointestinal oncology\| PubMed ID: 28280630	2017
Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research. Carcinogenesis\| PubMed ID: 28379317	2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials. BMC cancer\| PubMed ID: 28403829	2017
Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue. Journal of pain and symptom management\| PubMed ID: 28502786	2017
Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology\| PubMed ID: 28511129	2017
Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma. International journal of molecular sciences\| PubMed ID: 28556791	2017
Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 28589310	2017
Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy. Muscle & nerve\| PubMed ID: 28881477	2017
Oxaliplatin induces muscle loss and muscle-specific molecular changes in Mice. Muscle & nerve\| PubMed ID: 28881481	2018
Evaluating the Impact of Functional Genetic Variation on HIV-1 Control. The Journal of infectious diseases\| PubMed ID: 28968755	2017
Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer. Oncotarget\| PubMed ID: 29100344	2017
Predictors of care for patients with cancer of unknown primary site in three Australian hospitals. Asia-Pacific journal of clinical oncology\| PubMed ID: 29105289	2018
Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated? ANZ journal of surgery\| PubMed ID: 29514401	2018
Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival. Asia-Pacific journal of clinical oncology\| PubMed ID: 29573158	2018
Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines. International journal of oncology\| PubMed ID: 29620166	2018
A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy. Contemporary clinical trials\| PubMed ID: 29680317	2018
Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgrounds. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 30327877	2019
Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture. Neuroscience letters\| PubMed ID: 30439399	2019
Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review. Journal of surgical oncology\| PubMed ID: 30636052	2019
Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 30756229	2019
Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 30972648	2019
Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test. Journal of cancer survivorship : research and practice\| PubMed ID: 31172429	2019
Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients. The journal of pain : official journal of the American Pain Society\| PubMed ID: 31325646	2020
Optimizing Clinical Screening for Chemotherapy-Induced Peripheral Neuropathy. Journal of pain and symptom management\| PubMed ID: 31374367	2019
Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments. Journal of the National Comprehensive Cancer Network : JNCCN\| PubMed ID: 31390588	2019
The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy. Acta oncologica (Stockholm, Sweden)\| PubMed ID: 31462137	2020
Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review. HPB : the official journal of the International Hepato Pancreato Biliary Association\| PubMed ID: 31635959	2020
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT). Practical radiation oncology\| PubMed ID: 31761541	2020
Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials. Hematological oncology\| PubMed ID: 31873944	2020
Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups. Asia-Pacific journal of clinical oncology\| PubMed ID: 31957344	2020
The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas. Oncotarget\| PubMed ID: 32002123	2020
Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis. British journal of cancer\| PubMed ID: 32203220	2020
The impact of anticancer drugs on the ocular surface. The ocular surface\| PubMed ID: 32344148	2020
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer. JAMA network open\| PubMed ID: 32407502	2020
Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer. Journal of hepatology\| PubMed ID: 32446715	2020
Stage pN3a in oral cancer: A redundant entity? Oral oncology\| PubMed ID: 32467072	2020
Acute changes in nerve excitability following oxaliplatin treatment in mice. Journal of neurophysiology\| PubMed ID: 32519566	2020
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer. Pancreas\| PubMed ID: 32541630	2020
Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy-a randomised controlled trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 32607598	2020
Self-reported health, lifestyle and social circumstances of Australian adult cancer survivors: A propensity score weighted cross-sectional study. Cancer epidemiology\| PubMed ID: 32615538	2020
Oxaliplatin-induced haematological toxicity and splenomegaly in mice. PloS one\| PubMed ID: 32877416	2020